Table 1.
Year | |||||||||
---|---|---|---|---|---|---|---|---|---|
Type | 2002 | % | 2003 | % | 2004 | % | Total | % | |
Usual* | |||||||||
P[4]G2x | 1 | 1 | 4 | 2 | 0 | 0 | 5 | 1 | |
P[6]G1 | 3 | 2 | 0 | 0 | 6 | 3 | 9 | 2 | |
P[6]G9xq | 3 | 2 | 4 | 2 | 5 | 2 | 12 | 2 | |
P[8]G1 | 90 | 51 | 79 | 47 | 63 | 30 | 232 | 42 | |
P[8]G9 | 23 | 13 | 36 | 21 | 25 | 12 | 84 | 15 | |
sub-total | 120 | 67 | 123 | 73 | 99 | 47 | 342 | 61 | |
Unusual* | |||||||||
P[4]G1 | 0 | 0 | 0 | 0 | 10 | 5 | 10 | 2 | |
P[4]G8xq | 3 | 2 | 7 | 4 | 28 | 13 | 38 | 7 | |
P[4]G9xq | 0 | 0 | 2 | 1 | 1 | 0 | 3 | 1 | |
P[6]G8xq | 17 | 10 | 1 | 1 | 15 | 7 | 33 | 6 | |
P[8]G2 | 4 | 2 | 1 | 1 | 1 | 0 | 6 | 1 | |
P[8]G8 | 8 | 4 | 1 | 1 | 13 | 6 | 22 | 4 | |
sub-total | 32 | 18 | 12 | 7 | 68 | 32 | 112 | 20 | |
Non-typeable & mixed% | |||||||||
P[4]GNTxq | 0 | 0 | 0 | 0 | 6 | 3 | 6 | 1 | |
P[6]GNTxq | 2 | 1 | 0 | 0 | 3 | 1 | 5 | 1 | |
P[8]GNT | 8 | 4 | 0 | 0 | 1 | 0 | 9 | 2 | |
P[NT]G1 | 5 | 3 | 5 | 3 | 2 | 1 | 12 | 2 | |
P[NT]G8xq | 1 | 1 | 1 | 1 | 1 | 0 | 3 | 1 | |
P[NT]G9xq | 2 | 1 | 2 | 1 | 2 | 1 | 6 | 1 | |
P[NT]GNT | 1 | 1 | 2 | 1 | 3 | 1 | 6 | 1 | |
mixed | 7 | 4 | 24 | 14 | 26 | 12 | 57 | 10 | |
sub-total | 26 | 15 | 34 | 20 | 44 | 21 | 104 | 19 | |
Total | 178 | 100 | 169 | 100 | 211 | 100 | 558 | 100 |
Notes:
Usual and unusual genotypes worldwide as defined by Santos and Hoshino[7]
P[NT], GNT, P[NT]GNT - non-typeable for VP4(P), VP7(G) or both, respectively.
types not included in Rotarix® (x) or Rotateq™ (q) vaccines